SWF file not found. Please check the path.
مقالات انگليسي-مطالعات پايه در مورد HTLV (ويرولوژي،ايمونولوژي، ژنتيك و ...)
مرتب سازی بر اساس عنوان مطلب
مرتب سازی بر اساس تاریخ ایجاد
Unpublished
Title Filter
Display #
5
10
15
20
25
30
50
100
All
Association between HLA-DQB1 alleles and HAM/TSP patients in Khorasan Province
Evaluation of HTLV-1 activity in HAM/TSP patients using proviral load and Tax mRNA expression after In Vitro lymphocyte activation
Examination of a Reporter Vector for HTLV-1 Infectivity Using MT2, a HTLV-1 Producer Cell Line
The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis -HAM/TSP
The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell leukemia lymphoma
Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma -ATL
HTLV-I Infection Twenty-Year Research in Neurology Department of Mashhad University of Medical Sciences
Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers
Association of IL-10 Gene Polymorphisms and Human T Lymphotropic Virus Type I-Associated Myelopathy/tropical Spastic Paraparesis in North-East of Iran -Mashhad
Association between HLA Class I Alleles and Proviral Load in HTLV-I Associated Myelopathy/Tropical Spastic araperesis -HAM/TSP-Patients in Iranian Population
The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLAclass I and plasma neopterin on manifestation of HTLV-1 associatedmyelopathy tropical spastic paraparesis
Status of soluble ST2 levels in serum of HTLV-1 infected individuals
Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical
Immunization against HTLV-I with chitosan and tri-methylchitosan nanoparticles loaded with recombinant env23 and env13 antigens of envelope protein gp46
Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
HTLV-1-host interactions facilitate the manifestations of cardiovascular disease
HTLV-1-infected asymptomatic carriers compared to HAM/TSP patients over-express the apoptosis- and cytotoxicity-related molecules
Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles
Role of Receptors for Advanced Glycation End Products and High-Mobility Group Box 1 in the Outcome of Human T Cell Lymphotropic Type 1 Infection
The novel immunogenic chimeric peptide vaccine to elicit potent cellular and mucosal immune responses against HTLV-1
Thioredoxin reductase gene expression and activity among human T-cell lymphotropic virus type 1-infected patients.
Modulatory effects of curcumin on apoptosis and cytotoxicity-related molecules in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients
Altered expression of CXCR3 and CCR6 and their ligands in HTLV-1 carriers and HAM/TSP patients
Interferon Lambda Family along with HTLV-1 Proviral Load, Tax, and HBZ Implicated in the Pathogenesis of Myelopathy/Tropical Spastic Paraparesis
Different roles of CXCR1 and CXCR2 in HTLV-1 carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients
DNA methyltransferases in virus-associated cancers
Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP
Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients
Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma
Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia
Evaluation of Interleukin-32 and cyclooxygenase-2 expression in HAM/TSP patients and HTLV-1 asymptomatic carriers
HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions
Molecular targeting for treatment of human T-lymphotropic virus type 1 infection
The Impact of CRISPR-Cas System on Antiviral Therapy
Study of the Effects of Combined Therapy with Sodium Valproate, Peg-interferon and Corticosteroid on Proviral Load of HTLV-1 and the Expression of Rel-A, Creb and IL-1 Genes in Patients with HTLV-1 associated Myelopathy/Tropical Spastic Paraparesis
A Functional Polymorphism of the Granulocyte Macrophage Colony Stimulating Factor is not Associated with the Outcome of HTLV-I Infection
Absence of FLT3 mutations in Iranian adult T-cell leukemia/lymphoma patients
Involvement of MicroRNA in T-Cell Differentiation and Malignancy
Prevalence of CCR5delta32 in Northeastern Iran
ANTIBODIES TO CARDIOLIPIN AND BETA 2-GLYCOPROTEIN-1 IN HTLV-1-ASSOCIATED MYELOPATHY TROPICAL SPASTIC PARAPARESIS
Association between HLA-DRB1*01 and HLACw*08 and Outcome Following HTLV-I Infection
Association of a novel single nucleotide polymorphism in the human perforin gene with the outcome of HTLV-I infection in patients from northeast Iran -Mash-had
Common origin of human T-lymphotropic virus type-I from Iran, Kuwait, Israel, and La Réunion Island
Role of the HTLV-1 viral factors in the induction of apoptosis
Comparison of antigenic sites of the envelope glycoprotein of the Iranian isolate of human T-cell leukemia virus type 1 with different subtypes of the virus
Detection of the soluble form of the Fas/Apo-1 receptor in patients with human T-lymphotropic virus type 1-associated myelopathy
Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals
Evaluation of Serum Interleukin-2Rα in HAM /TSP Patients and HTLV-I Carriers in Mashhad-Iran
Expression of Interleukin-2Rα chain (CD25) on peripheral blood lymphocytes in HTLV-I associated myelopathy/ tropical spastic paraparesis patients
HLA and HTLV-workshop report
HTLV-I from Iranian Mashhadi Jews in Israel is phylogenetically related to that of Japan, India, and South America rather than to that of Africa and Melanesia
HTLV-I Infection: Virus structure, Immune Response to the Virus and Genetic Association Studies in HTLV-I-Infected Individuals
Human T-cell lymphotropic virus type I in Iranian-born Mashhadi Jews: genetic and phylogenetic evidence for common source of infection
Human T-lymphotropic virus type-1 (HTLV-1) in Israeli patients and their family relatives and its transmission to rats
Increased microvessel density in involved organs from patients with HTLV-I associated adult T cell leukemia lymphoma
Molecular analysis of human T cell lymphotropic virus type 1 and 2 -HTLV-1/2- seroindeterminate blood donors from Northeast Iran: evidence of proviral tax, env, and gag sequences
Molecular characterization of human T-lymphotropic virus, type 1- HTLV-1- found in Kuwait: close similarity with HTLV-1 isolates originating from Mashhad, Iran
Molecular Studies of HTLV-I Infection in Newly Recognized High Risk Population
New insights in HTLV-I phylogeny by sequencing and analyzing the entire envelope gene
Phylogenetic classification of human T cell leukaemia/lymphoma virus type I genotypes in five major molecular and geographical subtypes
Phylogenetic of human T-cell lymphotropic virus type I in Iranians born in Mashhad
Phylogenetic relationships of HTLV-I/STLV-I in the world
POLYMORPHISM IN THE INTERLEUKIN-10 PROMOTER AFFECTS BOTH PROVIRUS LOAD AND THE RISK OF HUMAN T LYMPHOTROPIC VIRUS TYPE I (HTLV-I) ASSOCIATED MYELOPATHY/ TROPICAL SPASTIC PARAPARESIS
Possible HLA association with susceptibility to HTLV-1 tropical spastic paraparesis in Israel in Iranian Jews as compared to HTLV 1-associated myelopathy in Japan
SIGNIFICANCE OF IGA ANTIPHOSPHOLIPID ANTIBODIES
SUBSTITUTIONS T→C 4783 AND T→C 6569 IN THE POL AND ENV GENES OF HTLV-I ARE CHARACTERISTIC FOR THE ISOLATES ORIGINATING IN THE MIDDLE EAST
The phylogenetic relationship of HTLV type I from non-Mashhadi Iranians to that from Mashhadi Jews
Transcriptional coactivator CBP facilitates transcription initiation and reinitiation of HTLV-1 and Cyclin D2 promoter
The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects
Phylogenetic and phylodynamic study of Human T-cell lymphotropic virus Type 1 (HTLV-1) in Iran
Status of humoral and cellular immune markers in human T-cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriers in northeastern Iran, Mashhad
In silico identification of epitope-based vaccine candidates against HTLV-1
HTLV-1 oncovirus-host interactions: From entry to the manifestation of associated diseases
Evaluation of iron, ferritin, copper, and ceruloplasmin along with proviral load in human T lymphotropic virus type 1–associated myelopathy